CISA Warned About Critical Vulnerabilities in Illumina’s DNA Sequencing Devices
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) and Food and Drug Administration (FDA) have issued an advisory about critical security vulnerabilities in Illumina’s next-generation sequencing (NGS) software.
Three of the flaws are rat…